Oncolytics Biotech Inc.
ONCY
$0.5702
-$0.0217-3.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.73M | -7.00M | -5.30M | -5.11M | -2.90M |
| Total Depreciation and Amortization | 57.20K | 77.00K | 71.60K | 91.20K | 78.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 750.80K | 212.60K | 90.60K | -493.20K | -2.80M |
| Change in Net Operating Assets | -685.80K | 3.16M | 157.10K | -24.50K | 1.12M |
| Cash from Operations | -5.61M | -3.54M | -4.98M | -5.54M | -4.50M |
| Capital Expenditure | -4.30K | -23.50K | -113.30K | -34.10K | -2.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -4.30K | -23.50K | -113.30K | -34.10K | -2.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00K | -80.00K | -65.00K | -103.00K | -104.00K |
| Issuance of Common Stock | 3.61M | 287.00K | 2.17M | 1.67M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -882.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -169.00K | -380.00K | -131.00K | -71.00K | 2.73M |
| Cash from Financing | 2.39M | -126.80K | 1.44M | 1.11M | 1.28M |
| Foreign Exchange rate Adjustments | 612.20K | -157.60K | 179.80K | 527.40K | -502.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.61M | -3.85M | -3.47M | -3.94M | -3.73M |